Home › NDC Lookup › RxCUI directory › RxCUI 857183

Fosinopril sodium 20 MG Oral Tablet — RxCUI 857183

RxNorm drug concept · Semantic clinical drug
RxCUI 857183 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 32 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI857183
Official nameFosinopril sodium 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asFNP Sodium 20 MG Oral Tablet
FDA products mapped16
Package NDCs mapped32
Reported Medicaid activity (SDUD)4,328 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fosinopril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats high blood pressure and helps manage heart failure. For heart failure it is added to your usual treatment, such as diuretics. It can be used alone or with a thiazide diur...
  • It is a tablet taken by mouth, usually once a day. You can take it with or without food. If you also take an antacid, space the two about 2 hours apart. Follow your prescriber's di...
  • The most common are cough, dizziness, nausea, headache, and tiredness. Many are mild and pass. A dry cough that won't go away is worth mentioning to your doctor.
  • Get emergency help if your face, lips, tongue, or throat swell, or if you have trouble breathing. Call your doctor for fainting, severe belly pain, or yellow skin or eyes.
📖 Read our full Fosinopril guide →

🕸️ Concept Web — How Fosinopril sodium 20 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fosinopril sodium 20 MG Oral Tablet RxCUI 857183

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Fosinopril 50166
    • Fosinopril sodium 227278
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fosinopril Oral Tablet 372274
    • Fosinopril sodium Oral Tablet 2646057
    • Fosinopril Oral Product 1162676
    • Fosinopril Pill 1162677
    • Fosinopril sodium Oral Product 2662241
    • Fosinopril sodium Pill 2663522
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fosinopril sodium 20 MG 857173

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fosinopril sodium 20 MG SCDC · 857173
  • Fosinopril Oral Tablet SCDF · 372274
  • Fosinopril sodium Oral Tablet SCDFP · 2646057
  • Fosinopril Oral Product SCDG · 1162676
  • Fosinopril Pill SCDG · 1162677
  • Fosinopril sodium Oral Product SCDGP · 2662241
  • Fosinopril sodium Pill SCDGP · 2663522

📦 FDA Products & Package NDCs

16 products · 32 package NDCs
32 package NDCs map to RxCUI 857183 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43547-0386-09 90 TABLET in 1 BOTTLE (43547-386-09) Fosinopril sodium Solco Healthcare LLC 2017-10-01
43547-0386-11 1000 TABLET in 1 BOTTLE (43547-386-11) Fosinopril sodium Solco Healthcare LLC 2017-10-01
43547-0387-09 90 TABLET in 1 BOTTLE (43547-387-09) Fosinopril sodium Solco Healthcare LLC 2017-10-01
43547-0387-11 1000 TABLET in 1 BOTTLE (43547-387-11) Fosinopril sodium Solco Healthcare LLC 2017-10-01
43547-0388-09 90 TABLET in 1 BOTTLE (43547-388-09) Fosinopril sodium Solco Healthcare LLC 2017-10-01
43547-0388-11 1000 TABLET in 1 BOTTLE (43547-388-11) Fosinopril sodium Solco Healthcare LLC 2017-10-01
62135-0041-90 90 TABLET in 1 BOTTLE (62135-041-90) Fosinopril Sodium Chartwell RX, LLC 2023-06-01
62135-0042-90 90 TABLET in 1 BOTTLE (62135-042-90) Fosinopril Sodium Chartwell RX, LLC 2023-06-01
62135-0043-90 90 TABLET in 1 BOTTLE (62135-043-90) Fosinopril Sodium Chartwell RX, LLC 2023-06-01
65862-0471-30 30 TABLET in 1 BOTTLE (65862-471-30) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0471-90 90 TABLET in 1 BOTTLE (65862-471-90) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0471-99 1000 TABLET in 1 BOTTLE (65862-471-99) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0472-30 30 TABLET in 1 BOTTLE (65862-472-30) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0472-90 90 TABLET in 1 BOTTLE (65862-472-90) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0472-99 1000 TABLET in 1 BOTTLE (65862-472-99) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0473-30 30 TABLET in 1 BOTTLE (65862-473-30) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0473-90 90 TABLET in 1 BOTTLE (65862-473-90) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
65862-0473-99 1000 TABLET in 1 BOTTLE (65862-473-99) Fosinopril Sodium Aurobindo Pharma Limited 2011-03-30
69097-0856-05 90 TABLET in 1 BOTTLE (69097-856-05) Fosinopril Sodium Cipla USA Inc. 2016-06-16
69097-0856-15 1000 TABLET in 1 BOTTLE (69097-856-15) Fosinopril Sodium Cipla USA Inc. 2016-06-16
69097-0857-05 90 TABLET in 1 BOTTLE (69097-857-05) Fosinopril Sodium Cipla USA Inc. 2016-06-16
69097-0857-15 1000 TABLET in 1 BOTTLE (69097-857-15) Fosinopril Sodium Cipla USA Inc. 2016-06-16
69097-0858-05 90 TABLET in 1 BOTTLE (69097-858-05) Fosinopril Sodium Cipla USA Inc. 2016-06-16
69097-0858-15 1000 TABLET in 1 BOTTLE (69097-858-15) Fosinopril Sodium Cipla USA Inc. 2016-06-16
71335-0187-01 30 TABLET in 1 BOTTLE (71335-0187-1) Fosinopril Sodium Bryant Ranch Prepack 2020-05-14
71335-0187-02 28 TABLET in 1 BOTTLE (71335-0187-2) Fosinopril Sodium Bryant Ranch Prepack 2021-12-27
76282-0200-10 1000 TABLET in 1 BOTTLE (76282-200-10) Fosinopril sodium Exelan Pharmaceuticals, Inc. 2005-06-21
76282-0200-90 90 TABLET in 1 BOTTLE (76282-200-90) Fosinopril sodium Exelan Pharmaceuticals, Inc. 2005-06-21
76282-0201-10 1000 TABLET in 1 BOTTLE (76282-201-10) Fosinopril sodium Exelan Pharmaceuticals, Inc. 2005-06-21
76282-0201-90 90 TABLET in 1 BOTTLE (76282-201-90) Fosinopril sodium Exelan Pharmaceuticals, Inc. 2005-06-21
76282-0202-10 1000 TABLET in 1 BOTTLE (76282-202-10) Fosinopril sodium Exelan Pharmaceuticals, Inc. 2005-06-21
76282-0202-90 90 TABLET in 1 BOTTLE (76282-202-90) Fosinopril sodium Exelan Pharmaceuticals, Inc. 2005-06-21
Observed labelers: Aurobindo Pharma Limited (9) · Cipla USA Inc. (6) · Exelan Pharmaceuticals, Inc. (6) · Solco Healthcare LLC (6) · Chartwell RX, LLC (3) · Bryant Ranch Prepack (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.